BioCentury | Nov 12, 2015
Targets & Mechanisms
Breaking down beliefs
Researchers at the Genentech Inc. unit of Roche are challenging the widely held belief that the blood-brain barrier (BBB) breaks down in Alzheimer's disease to cause neurodegeneration and acts as a gateway for delivery of...